RedHill Biopharma Ltd. Quarterly Assets in USD from Q4 2016 to Q4 2023

Taxonomy & unit
ifrs-full: USD
Summary
RedHill Biopharma Ltd. quarterly Assets history and growth rate from Q4 2016 to Q4 2023.
  • RedHill Biopharma Ltd. Assets for the quarter ending December 31, 2023 was $23M, a 85.5% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $23M -$136M -85.5% Dec 31, 2023 20-F 2024-04-08
Q2 2023 $35M -$133M -79.1% Jun 30, 2023 6-K 2023-08-17
Q4 2022 $159M -$22.3M -12.3% Dec 31, 2022 20-F 2024-04-08
Q2 2022 $168M -$35.7M -17.5% Jun 30, 2022 6-K 2022-11-07
Q4 2021 $181M +$947K +0.53% Dec 31, 2021 20-F 2023-04-28
Q2 2021 $204M +$37.3M +22.4% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $180M +$106M +143% Dec 31, 2020 20-F 2022-03-17
Q2 2020 $166M +$117M +235% Jun 30, 2020 6-K 2020-08-13
Q4 2019 $74.1M +$11.7M +18.7% Dec 31, 2019 20-F 2021-03-18
Q2 2019 $49.7M +$11.8M +31.3% Jun 30, 2019 6-K 2019-07-23
Q4 2018 $62.4M +$5.07M +8.84% Dec 31, 2018 20-F 2020-03-04
Q2 2018 $37.8M Jun 30, 2018 6-K 2018-08-30
Q4 2017 $57.3M -$16.9M -22.7% Dec 31, 2017 20-F 2019-02-26
Q4 2016 $74.2M Dec 31, 2016 20-F 2018-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.